Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-3 and related prospectus of Cancer Genetics, Inc. of our report dated April 15, 2019, relating to the consolidated financial statements of Cancer Genetics, Inc. and Subsidiaries as of December 31, 2018 and for the year then ended, before the effects of the adjustments for discontinued operations and a reverse stock-split, appearing in the Annual Report on Form 10-K of Cancer Genetics, Inc. for the year ended December 31, 2019.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
New York, NY
February 1, 2021
